Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Cuttner

Showing results (71-80 of 89) with videos related to

Pageof 9
Sort By:
Blood|March 1, 1985
Adult acute lymphoblastic leukemia phenotypes defined by monoclonal antibodiesR E Sobol, I Royston, T W LeBien, et al.
Leukemia|May 1, 1991
Phase III trial of brief intensive treatment of adult acute lymphocytic leukemia comparing daunorubicin and mitoxantrone: a CALGB StudyJ Cuttner, R Mick, D R Budman, et al.
Cancer Chemotherapy Reports|June 1, 1971
Treatment of adult leukemia with L-asparaginase (NSC-109229)T Onuma, F Rosner, R N Levy, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 1, 1991
The effects of postinduction intensification treatment with cytarabine and daunorubicin in adult acute lymphocytic leukemia: a prospective randomized clinical trial by Cancer and Leukemia Group BR R Ellison, R Mick, J Cuttner, et al.
Archives of Internal Medicine|December 1, 1976
Acute myelocytic leukemiaJ F Holland, O Glidewell, R R Ellison, et al.
Medical and Pediatric Oncology|January 1, 1979
Combination chemotherapy for non-Hodgkin lymphomas: a ten year follow-up studyD M Hayes, T F Pajak, V Rege, et al.
Medical and Pediatric Oncology|January 1, 1979
A comparative trial of daunorubicin, cytosine arabinoside, and thioguanine, and a combination of the three agents for the treatment of acute myelocytic leukemiaP H Wiernik, O J Glidewell, H C Hoagland, et al.
Medical and Pediatric Oncology|January 1, 1975
The use of low-dose prednisone and melphalan in the treatment of poor-risk patients with multiple myelomaJ Cuttner, L R Wasserman, G Martz, et al.
Cancer|January 15, 1980
Clinical trial of VP 16--213 (NSC 141540) I.V. twice weekly in advanced neoplastic disease: a study by the Cancer and Leukemia Group BN I Nissen, T F Pajak, L A Leone, et al.
Cancer|November 1, 1982
Comparison of oral melphalan, CCNU, and BCNU with and without vincristine and prednisone in the treatment of multiple myeloma. Cancer and Leukemia Group B experienceG G Cornwell, T F Pajak, S Kochwa, et al.
Pageof 9

Showing results (71-80 of 89) with videos related to

Sort By:
Pageof 9
Blood|March 1, 1985
Adult acute lymphoblastic leukemia phenotypes defined by monoclonal antibodiesR E Sobol, I Royston, T W LeBien, et al.
Leukemia|May 1, 1991
Phase III trial of brief intensive treatment of adult acute lymphocytic leukemia comparing daunorubicin and mitoxantrone: a CALGB StudyJ Cuttner, R Mick, D R Budman, et al.
Cancer Chemotherapy Reports|June 1, 1971
Treatment of adult leukemia with L-asparaginase (NSC-109229)T Onuma, F Rosner, R N Levy, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 1, 1991
The effects of postinduction intensification treatment with cytarabine and daunorubicin in adult acute lymphocytic leukemia: a prospective randomized clinical trial by Cancer and Leukemia Group BR R Ellison, R Mick, J Cuttner, et al.
Archives of Internal Medicine|December 1, 1976
Acute myelocytic leukemiaJ F Holland, O Glidewell, R R Ellison, et al.
Medical and Pediatric Oncology|January 1, 1979
Combination chemotherapy for non-Hodgkin lymphomas: a ten year follow-up studyD M Hayes, T F Pajak, V Rege, et al.
Medical and Pediatric Oncology|January 1, 1979
A comparative trial of daunorubicin, cytosine arabinoside, and thioguanine, and a combination of the three agents for the treatment of acute myelocytic leukemiaP H Wiernik, O J Glidewell, H C Hoagland, et al.
Medical and Pediatric Oncology|January 1, 1975
The use of low-dose prednisone and melphalan in the treatment of poor-risk patients with multiple myelomaJ Cuttner, L R Wasserman, G Martz, et al.
Cancer|January 15, 1980
Clinical trial of VP 16--213 (NSC 141540) I.V. twice weekly in advanced neoplastic disease: a study by the Cancer and Leukemia Group BN I Nissen, T F Pajak, L A Leone, et al.
Cancer|November 1, 1982
Comparison of oral melphalan, CCNU, and BCNU with and without vincristine and prednisone in the treatment of multiple myeloma. Cancer and Leukemia Group B experienceG G Cornwell, T F Pajak, S Kochwa, et al.
Pageof 9